1 / 8

Saudi Arabia Pharmaceutical Drugs Market Analysis-2027

u201cCoherent Market Insights u201cSAUDI ARABIA PHARMACEUTICAL DRUGS MARKET u2013 GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027u2033

SANJAYCMI
Download Presentation

Saudi Arabia Pharmaceutical Drugs Market Analysis-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SAUDI ARABIA PHARMACEUTICAL DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Saudi Arabia Pharmaceutical Drugs Market - Overview Saudi Arabia Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over-the-counter (OTC) Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Nervous System, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, and Others (Nutraceutical, dentals and veterian)), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy , and Online Pharmacy ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 10,191.4 million in 2020 and is expected to exhibit a CAGR of 7.3% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. The major manufacturers are focused on developing and launching pharmaceutical drugs with improved therapeutic effects and different dosage forms for ease of administration and patient convenience, which is expected to gain significant traction in the Saudi Arabia pharmaceutical drugs market. For instance, in September 2019, Celltrion Inc., a South Korean pharmaceutical company, launched its breast and gastric cancer biosimilar ‘Herzuma’ in Iraq and its second copy drug release in the Middle East region. Moreover, the drug was also launched in Jordan, Israel, the United Arab Emirates, Saudi Arabia, and Morocco. In May 2018, Hikma Pharmaceuticals LLC, in partnership with Basilea Pharmaceutica Ltd., announced the launch of Basilea’s hospital antibiotic ‘Ceftobiprole’ in Saudi Arabia. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/saudi- arabia-pharmaceuticals-market-3557 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION In December 2017, pharmaceutical company Jamjoom Pharma announced the launch of its new product Veratol, the first of its kind in Saudi Arabia and the Middle East. Veratol (Resveratrol) is most commonly used for high cholesterol, cancer, heart disease, and other conditions. In May 2014, Novo Nordisk announced the launch of new drug Victoza (Liraglutide), which is a revolutionary new treatment for type 2 diabetes in Saudi Arabia. Victoza provides significant glycemic control and delays disease progression in type 2 diabetes patients. Saudi Arabia Pharmaceutical Drugs Market - Impact of Coronavirus (Covid-19) Pandemic The coronavirus pandemic has negatively impacted the development, production, and supply of pharmaceutical drugs across the world. Many production and manufacturing facilities, and transport departments have suspended various activities in their factories of pharmaceutical drugs to stop the spread of coronavirus. Thus, this pandemic has affected both demand and supply of pharmaceutical drugs in Saudi Arabia. The Kingdom of Saudi Arabia (KSA) is launching and approving new drugs and medications to combat the spread of coronavirus, which is expected to propel the Saudi Arabia pharmaceuticals drugs market growth. For instance, in June 2020, the Saudi Arabia’s Health Ministry approved the use of steroid dexamethasone as part of its treatment protocol for COVID-19 patients. Dexamenthasone has been used to treat inflammation in diseases such as arthritis. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3557 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION After the spread of coronavirus, major companies operating in Saudi Arabia pharmaceutical drugs market are collaborating for the development of medications and vaccines to treat coronavirus infection. For instance, in June 2020, a Saudi Arabian company SaudiVax started developing a coronavirus preventative drug in collaboration with American scientists at the Center for Antibody Therapeutics, University of Pittsburgh, Pennsylvania, U.S. to discover the antibody and to get license for the drug in the Middle East region. Similarly, in April 2020, King Abdullah University of Science and Technology formed a group of faculty, the Rapid Research Response Team (R3T). Browse 44 Market Data Tables and 43 Figures spread through 153 Pages and in-depth TOC on Saudi Arabia Pharmaceutical Drugs Market, by Drug Type (Generic Drugs and Branded Drugs), by Product Type (Prescription Drugs and Over-the-counter (OTC) Drugs), by Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Central Nervous System, Gastrointestinal, Respiratory, Hematology, Dermatology, Ophthalmology, and Others (Nutraceutical, dentals and veterian)), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy , and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Forecast to 2027" Key Takeaways of the Saudi Arabia Pharmaceutical Drugs Market: The Saudi Arabia pharmaceutical drugs market is expected to exhibit a CAGR of 7.3% during the forecast period (2020-2027), owing to increasing launches and approval of drugs Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3557 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved

More Related